Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Start-Up Spotlight: GlucoModicum Plans To Disrupt Glucose Monitoring With Painless Wearable

Executive Summary

Medtech Insight spoke to the CEO of GlucoModicum to learn more about its approach to developing a pain-free, convenient glucose monitor for people managing their diabetes.

You may also be interested in...



Nemaura’s SugarBEAT Non-Invasive CGM Earns CE Mark

SugarBEAT is a non-invasive, needle-free, disposable adhesive skin-patch connected to a rechargeable transmitter. The company says it is the world’s first non-invasive continuous glucose monitor.

Paige Secures Eighth CE Mark For Cancer Identification AI

The Memorial Sloan Kettering spin-out has received CE-IVD and UKCA marks for its artificial intelligence software designed to identify HER2 expression in biopsies.

What Do Speedboats Have To Do with Surgery?

Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

MT143843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel